Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD16 binding molecules

Anti-CD16 binding molecules

US Patent 9701750 · Granted Jul 11, 2017

Estimated economic value: $1,922,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tandem diabody for CD16A-directed NK-cell engagement2025
Tandem diabody for CD16A-directed NK-cell engagement2025
Bispecific EGFR/CD16 antigen-binding protein2024
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for t2023
Multivalent FV antibodies2023
Drug conjugates comprising antibodies against claudin 18.22023
Combination of an anti-CD16A antibody with a cytokine2022
Bispecific EGFR/CD16 antigen-binding protein2022
Tandem diabody for CD16A-directed NK-cell engagement2021
Tandem diabody for CD16A-directed NK-cell engagement2021
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy2021
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy2021